Drug therapy in pulmonary hypertension
Choice of anaesthetic agents in coronary patients (2003)
Anti-pseudomonal agents
Ganciclovir
Repaglinide
Chloroquine
Radio-active iodine
Benzodiazepines
Anti-viral agents (2)
Anti-retroviral drugs (2)
Anti-helminthics (2)
Anti-arrhythmics (2)
Coagulants and anti-coagulants
Anti-thyroid drugs
Amiodarone
Indapanide
Quinine
Vancomycin
Newer anti-platelet drugs
Newer macrolides (2)
Side effects of carbamazepine
Clinical advantages of carbidopa
ARBs
Azithromycin – indications, adverse reactions
Bosentan
Carbapenems
Daptomycin – indications and adverse reactions
Sodium nitroprusside
ACE inhibitors
ARBs
Newer antidepressants
Tolvaptan
Newer antimalarials
H1 blockers
H2 blockers
Stem cell therapy (2)
Classify diuretics, add note on metolazone
Loop diuretics
Furosemide
Forced diuresis
Biologic therapy in treatment of malignancy
Tenofovir
Orciprenaline
Rate controlling CCBs
Gut sterilisers
Newer anxiolytics
Rifampin
Ivermectin (2)
Tafenoquine
Vasodilators in CCF
Beta lactamase inhibitors
Digoxin
Insulin resistance (2)
Methotrexate
Tricyclic antidepressants
Adverse effects and uses of aspirin
Aspirin resistance
Classification of anti-hypertensive drugs
DOTS therapy
Anti-amoebic drugs (2)
Drug addiction (2)
Antimitotics
Nitric oxide (2)
Drug interactions
Sulfasalazine
Vitamin excess
Newer quinolones
Anti-malarial drugs